FENC
FENNEC PHARMACEUTICALS INC. · Healthcare · Market cap $361.9M
Insiders sold $1.4M net in the last 90 days ·4 sellers, 0 buyers· 4 of 5 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 16, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$11.9M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Oct 13, 2026
Brughera Marco Maria
FENNEC PHARMACEUTICALS INC. (FENC) has 73 SEC Form 4 filings (103 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Oct 13, 2026.
Inside the rolling window, 6 insiders at FENNEC PHARMACEUTICALS INC. reported no open-market purchases and 19 open-market sales totaling $11.9M. The most active filer is Insider Raykov Rosty with 11 filings. Insiders have net sold $1.7M over the trailing 6 months. The most recent open-market filing is a sale of 15,545 shares by Director Brughera Marco Maria, dated Sep 15, 2026, worth $160K.
- Industry:Biotechnology
- CEO:Jeffrey S. Hackman
- Employees:35
- HQ:Research Triangle Park, NC, US
- IPO:2017-09-15
| Source | |||||||
|---|---|---|---|---|---|---|---|
Brughera Marco MariaFirst filing | Director | Sale | 15,545 | $160K | Sep 16 | -2.2% | SEC ↗ |
Sayad Pierre SargisFirst filing | Chief Medical Officer | Sale | 12,000 | $146K | Sep 1 | -14.2% | SEC ↗ |
| Former Director | Sale | 10,000 | $121K | Sep 1 | -14.2% | SEC ↗ | |
Andrade RobertFirst filing | CHIEF FINANCIAL OFFICER | Sale | 75,000 | $884K | Aug 28 | -15.9% | SEC ↗ |
| Former Director | Sale | 10,000 | $96K | Aug 4 | +2.1% | SEC ↗ | |
| Former Director | Sale | 9,599 | $100K | Jul 2 | -3.6% | SEC ↗ | |
| Director | Sale | 9,747 | $94K | Jun 2 | +3.4% | SEC ↗ | |
RALLIS CHRIS AFirst filing | Director | Sale | 8,346 | $59K | May 12 | +46.8% | SEC ↗ |
| Director | Sale | 10,781 | $70K | May 1 | +57.8% | SEC ↗ | |
| Director | Sale | 10,946 | $69K | Apr 2 | +60.7% | SEC ↗ | |
| Director | Sale | 10,079 | $84K | Mar 3 | — | SEC ↗ | |
| Director | Sale | 10,349 | $80K | Feb 2 | — | SEC ↗ | |
| Director | Sale | 10,312 | $78K | Jan 5 | — | SEC ↗ | |
| 10% Owner | Sale | 1,000,000 | $7.5M | Dec 29 | — | SEC ↗ | |
| Director | Sale | 10,000 | $75K | Dec 5 | — | SEC ↗ | |
| 10% Owner | Sale | 19,341 | $170K | Nov 20 | — | SEC ↗ | |
Southpoint Capital Advisors LPFirst filing | 10% Owner | Sale | 160,100 | $1.3M | Nov 17 | — | SEC ↗ |
Southpoint Capital Advisors LPFirst filing | 10% Owner | Sale | 85,918 | $755K | Nov 17 | — | SEC ↗ |
Raykov RostyFirst filing | Director | Sale | 10,000 | $81K | Nov 6 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does FENC have?
FENNEC PHARMACEUTICALS INC. (FENC) has 73 SEC Form 4 filings (103 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Oct 13, 2026.
When was the most recent SEC Form 4 filing for FENC?
The most recent Form 4 filing for FENC on Tracefour is dated Oct 13, 2026.
Who is the most active insider at FENC?
The most active SEC Form 4 filer at FENC in the rolling window is Insider Raykov Rosty, with 11 filings.
What is the net insider flow at FENC over the last 6 months?
Over the trailing 180 days, insiders at FENC have net sold $1.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at FENC in the current window?
Inside the rolling window, insiders at FENC bought $0 and sold $11.9M based on SEC Form 4 filings.
Can I get alerts for FENC insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at FENNEC PHARMACEUTICALS INC. (FENC). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
FENNEC PHARMACEUTICALS INC. is in the Healthcare sector.